Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Guided Therapeutics Inc

Market Cap 28M 24.39M 22.49M 21.15M 39.57M 2.64B 39.85M 268M 104M 1.3B 105M 103M 4.51B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 30.87M 26.9M 24.8M 23.32M 43.63M 2.91B 43.94M 295M 115M 1.43B 116M 113M 4.97B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%-2.32%+18.35%-13.53% 173B
+1.14%-1.48%-20.16%+23.51% 144B
-0.33%-2.00%-8.88%-26.73% 125B
+0.76%-3.99%-55.32%-16.62% 67.32B
+0.78%+1.87%+18.09%-4.98% 50.3B
+0.44%-0.06%-24.60%-33.93% 44.09B
+2.20%-1.92%+9.99%+4.90% 35.89B
-0.44%-1.20%+4.74%+32.04% 34.9B
+0.72%-4.53%-14.33%-21.69% 28.02B
Average +0.66%-2.12%-8.01%-6.34% 78.07B
Weighted average by Cap. +0.61%-2.00%-6.58%-6.38%

Financials

2024 2025
Net sales 7K 6.1K 5.62K 5.29K 9.89K 660K 9.96K 66.89K 25.98K 325K 26.27K 25.71K 1.13M 767K 668K 616K 579K 1.08M 72.29M 1.09M 7.33M 2.85M 35.62M 2.88M 2.82M 123M
Net income -2.42M -2.11M -1.94M -1.83M -3.42M -228M -3.44M -23.1M -8.97M -112M -9.07M -8.88M -389M -3.2M -2.78M -2.57M -2.41M -4.52M -301M -4.55M -30.54M -11.86M -148M -12M -11.74M -514M
Net Debt 1.77M 1.54M 1.42M 1.34M 2.5M 167M 2.52M 16.92M 6.57M 82.25M 6.65M 6.51M 285M 2.88M 2.51M 2.31M 2.17M 4.06M 271M 4.09M 27.48M 10.67M 134M 10.8M 10.56M 463M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!